feed,title,long_url,short_url
Benzinga,"New York Mortgage Trust Declares Fourth Quarter 2020 Common Stock Dividend of $0.10 Per Share, and Preferred Stock Dividends",https://www.benzinga.com/pressreleases/20/12/g18682798/new-york-mortgage-trust-declares-fourth-quarter-2020-common-stock-dividend-of-0-10-per-share-and-p,https://j.mp/36V7VbM
Benzinga,Oncocyte Corporation Hosting Key Opinion Leader Call on Proprietary Molecular Tests for Cancer Treatment Selection,https://www.benzinga.com/pressreleases/20/12/g18682797/oncocyte-corporation-hosting-key-opinion-leader-call-on-proprietary-molecular-tests-for-cancer-tre,https://j.mp/39S3ArI
Benzinga,Avid Bioservices Announces Appointment of Jeanne Thoma to Board of Directors,https://www.benzinga.com/pressreleases/20/12/g18682795/avid-bioservices-announces-appointment-of-jeanne-thoma-to-board-of-directors,https://j.mp/33Oc3rW
Benzinga,"Financial Institutions, Inc. Announces Agreement to Acquire Landmark Group",https://www.benzinga.com/pressreleases/20/12/g18682794/financial-institutions-inc-announces-agreement-to-acquire-landmark-group,https://j.mp/3mW80RM
Benzinga,"Stitch Fix Announces Dan Jedda As New CFO, Joining the Company From Amazon",https://www.benzinga.com/pressreleases/20/12/g18682793/stitch-fix-announces-dan-jedda-as-new-cfo-joining-the-company-from-amazon,https://j.mp/3lVmDU8
Benzinga,Trillium Therapeutics Presented Clinical Data at the 62nd ASH Annual Meeting and Provides Guidance for 2021,https://www.benzinga.com/pressreleases/20/12/g18682791/trillium-therapeutics-presented-clinical-data-at-the-62nd-ash-annual-meeting-and-provides-guidance,https://j.mp/3mTgLMJ
Benzinga,Kinnate Biopharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares,https://www.benzinga.com/pressreleases/20/12/g18682789/kinnate-biopharma-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwr,https://j.mp/3gtXvmr
Benzinga,"Annovis Bio to Present at Benzinga Global Small Cap Conference on December 8, 2020",https://www.benzinga.com/pressreleases/20/12/g18682788/annovis-bio-to-present-at-benzinga-global-small-cap-conference-on-december-8-2020,https://j.mp/3gtXwH1
Benzinga,Tricida to Provide an End-of-Year Business Update,https://www.benzinga.com/pressreleases/20/12/g18682786/tricida-to-provide-an-end-of-year-business-update,https://j.mp/2K4CfI0
Benzinga,"Harpoon Therapeutics to Host Clinical Pipeline Programs Update Call and Webcast on December 8, 2020",https://www.benzinga.com/pressreleases/20/12/g18682785/harpoon-therapeutics-to-host-clinical-pipeline-programs-update-call-and-webcast-on-december-8-2020,https://j.mp/36ROEYp
Benzinga,"Corum Client Big Blue Bubble, Gaming Pioneer, Acquired by EG7 Group",https://www.benzinga.com/pressreleases/20/12/g18682693/corum-client-big-blue-bubble-gaming-pioneer-acquired-by-eg7-group,https://j.mp/2VN9LVt
Benzinga,iBio Announces Proposed Public Offering of Common Stock,https://www.benzinga.com/pressreleases/20/12/g18682641/ibio-announces-proposed-public-offering-of-common-stock,https://j.mp/36TkwMl
Benzinga,Opiant Pharmaceuticals Announces Appointment of Biopharmaceutical Leader Craig A. Collard as Chairman to its Board of Directors,https://www.benzinga.com/pressreleases/20/12/g18682638/opiant-pharmaceuticals-announces-appointment-of-biopharmaceutical-leader-craig-a-collard-as-chairm,https://j.mp/2VN2tkP
Benzinga,Inventiva announces the publication in the Journal of Hepatology of new pre-clinical data showing the beneficial effects of lanifibranor on cirrhosis,https://www.benzinga.com/pressreleases/20/12/g18682615/inventiva-announces-the-publication-in-the-journal-of-hepatology-of-new-pre-clinical-data-showing-,https://j.mp/39UynUD
Benzinga,Espey Declares Regular Quarterly Dividend of $0.25 Per Share,https://www.benzinga.com/pressreleases/20/12/g18682614/espey-declares-regular-quarterly-dividend-of-0-25-per-share,https://j.mp/3qEyzgA
